Cargando…
The Anticancer Action of a Novel 1,2,4-Triazine Sulfonamide Derivative in Colon Cancer Cells
Cancer therapy is one of the most important challenges of modern medical and chemical sciences. Among the many methods of combating cancer, chemotherapy plays a special role. Imperfect modern chemotherapy justifies continuing the search for new, more effective, and safe drugs. Sulfonamides are the c...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038278/ https://www.ncbi.nlm.nih.gov/pubmed/33918514 http://dx.doi.org/10.3390/molecules26072045 |
_version_ | 1783677338378043392 |
---|---|
author | Gornowicz, Agnieszka Szymanowska, Anna Mojzych, Mariusz Czarnomysy, Robert Bielawski, Krzysztof Bielawska, Anna |
author_facet | Gornowicz, Agnieszka Szymanowska, Anna Mojzych, Mariusz Czarnomysy, Robert Bielawski, Krzysztof Bielawska, Anna |
author_sort | Gornowicz, Agnieszka |
collection | PubMed |
description | Cancer therapy is one of the most important challenges of modern medical and chemical sciences. Among the many methods of combating cancer, chemotherapy plays a special role. Imperfect modern chemotherapy justifies continuing the search for new, more effective, and safe drugs. Sulfonamides are the classic group of chemotherapeutic drugs with a broad spectrum of pharmacological activity. Recent literature reports show that sulfonamide derivatives have anti-tumor activity in vitro and in vivo. The aim of the study was to synthesize a novel 1,2,4-triazine sulfonamide derivative and check its anticancer potential in DLD-1 and HT-29 colon cancer cells. The biological studies included MTT assay, DNA biosynthesis, cell cycle analysis, Annexin V binding assay, ethidium bromide/acridine orange staining, and caspase-8, -9, and -3/7 activity. The concentrations of important molecules (sICAM-1, mTOR, Beclin-1, cathepsin B) involved in the pathogenesis and poor prognosis of colorectal cancer were also evaluated by ELISA. We demonstrated that the novel compound was able to induce apoptosis through intrinsic and extrinsic pathways and was capable of decreasing sICAM-1, mTOR, cathepsin B concentrations, whereas increased Beclin-1 concentration was detected in both colon cancer cell lines. The novel compound represents promising multi-targeted potential in colorectal cancer, but further in vivo examinations are needed to confirm the claim. |
format | Online Article Text |
id | pubmed-8038278 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80382782021-04-12 The Anticancer Action of a Novel 1,2,4-Triazine Sulfonamide Derivative in Colon Cancer Cells Gornowicz, Agnieszka Szymanowska, Anna Mojzych, Mariusz Czarnomysy, Robert Bielawski, Krzysztof Bielawska, Anna Molecules Article Cancer therapy is one of the most important challenges of modern medical and chemical sciences. Among the many methods of combating cancer, chemotherapy plays a special role. Imperfect modern chemotherapy justifies continuing the search for new, more effective, and safe drugs. Sulfonamides are the classic group of chemotherapeutic drugs with a broad spectrum of pharmacological activity. Recent literature reports show that sulfonamide derivatives have anti-tumor activity in vitro and in vivo. The aim of the study was to synthesize a novel 1,2,4-triazine sulfonamide derivative and check its anticancer potential in DLD-1 and HT-29 colon cancer cells. The biological studies included MTT assay, DNA biosynthesis, cell cycle analysis, Annexin V binding assay, ethidium bromide/acridine orange staining, and caspase-8, -9, and -3/7 activity. The concentrations of important molecules (sICAM-1, mTOR, Beclin-1, cathepsin B) involved in the pathogenesis and poor prognosis of colorectal cancer were also evaluated by ELISA. We demonstrated that the novel compound was able to induce apoptosis through intrinsic and extrinsic pathways and was capable of decreasing sICAM-1, mTOR, cathepsin B concentrations, whereas increased Beclin-1 concentration was detected in both colon cancer cell lines. The novel compound represents promising multi-targeted potential in colorectal cancer, but further in vivo examinations are needed to confirm the claim. MDPI 2021-04-02 /pmc/articles/PMC8038278/ /pubmed/33918514 http://dx.doi.org/10.3390/molecules26072045 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gornowicz, Agnieszka Szymanowska, Anna Mojzych, Mariusz Czarnomysy, Robert Bielawski, Krzysztof Bielawska, Anna The Anticancer Action of a Novel 1,2,4-Triazine Sulfonamide Derivative in Colon Cancer Cells |
title | The Anticancer Action of a Novel 1,2,4-Triazine Sulfonamide Derivative in Colon Cancer Cells |
title_full | The Anticancer Action of a Novel 1,2,4-Triazine Sulfonamide Derivative in Colon Cancer Cells |
title_fullStr | The Anticancer Action of a Novel 1,2,4-Triazine Sulfonamide Derivative in Colon Cancer Cells |
title_full_unstemmed | The Anticancer Action of a Novel 1,2,4-Triazine Sulfonamide Derivative in Colon Cancer Cells |
title_short | The Anticancer Action of a Novel 1,2,4-Triazine Sulfonamide Derivative in Colon Cancer Cells |
title_sort | anticancer action of a novel 1,2,4-triazine sulfonamide derivative in colon cancer cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038278/ https://www.ncbi.nlm.nih.gov/pubmed/33918514 http://dx.doi.org/10.3390/molecules26072045 |
work_keys_str_mv | AT gornowiczagnieszka theanticanceractionofanovel124triazinesulfonamidederivativeincoloncancercells AT szymanowskaanna theanticanceractionofanovel124triazinesulfonamidederivativeincoloncancercells AT mojzychmariusz theanticanceractionofanovel124triazinesulfonamidederivativeincoloncancercells AT czarnomysyrobert theanticanceractionofanovel124triazinesulfonamidederivativeincoloncancercells AT bielawskikrzysztof theanticanceractionofanovel124triazinesulfonamidederivativeincoloncancercells AT bielawskaanna theanticanceractionofanovel124triazinesulfonamidederivativeincoloncancercells AT gornowiczagnieszka anticanceractionofanovel124triazinesulfonamidederivativeincoloncancercells AT szymanowskaanna anticanceractionofanovel124triazinesulfonamidederivativeincoloncancercells AT mojzychmariusz anticanceractionofanovel124triazinesulfonamidederivativeincoloncancercells AT czarnomysyrobert anticanceractionofanovel124triazinesulfonamidederivativeincoloncancercells AT bielawskikrzysztof anticanceractionofanovel124triazinesulfonamidederivativeincoloncancercells AT bielawskaanna anticanceractionofanovel124triazinesulfonamidederivativeincoloncancercells |